Indications for PTCA in CAD with Triple Vessel Disease

When CABG is the Clear Choice

• The American College of Cardiology recommends CABG for triple vessel disease with abnormal left ventricular function (LVEF <0.50) to improve survival, as the survival benefit is greater in patients with reduced ejection fraction 4
• The American Heart Association probably recommends CABG over PCI for multivessel CAD with diabetes mellitus, particularly when a left internal mammary artery graft can be anastomosed to the LAD artery 1, 2, 3
• CABG should be chosen over PCI for complex 3-vessel CAD (SYNTAX score >22) with or without proximal LAD involvement in patients who are good surgical candidates 1, 2, 3

Limited Scenarios Where PCI May Be Considered

Class IIa (Reasonable Option)

• PCI is reasonable for triple vessel disease with severe angina when patients have favorable anatomy with high likelihood of success and low procedural risk 5, 6
• PCI can be considered for focal lesions or multiple stenoses in patients who are poor candidates for reoperative surgery 5, 4, 6

Class IIb (May Be Considered, But Uncertain Benefit)

• PCI may be considered for 2- or 3-vessel disease with significant proximal LAD CAD in patients with treated diabetes or abnormal left ventricular function when anatomy is suitable for catheter-based therapy 4, 7, 8
• The effectiveness of PCI is not well established for mild angina with 2- or 3-vessel disease and proximal LAD involvement in patients eligible for CABG 5, 6
• The usefulness of PCI to improve survival is uncertain in patients with 2- or 3-vessel CAD regardless of proximal LAD involvement 1, 2, 3

Absolute Contraindications to PCI (Class III)

• PCI should not be performed for triple vessel disease with significant left main CAD (>50% stenosis) when the patient is a candidate for CABG 5, 4, 7, 8, 6
• PCI is not recommended without objective evidence of ischemia on noninvasive testing 5, 6
• PCI should not be performed when only a small area of myocardium is at risk 5, 6
• PCI is contraindicated when lesion morphology conveys low likelihood of success or high procedural risk 5, 6

Critical Clinical Context

Symptom Relief vs. Survival Benefit

• For low-risk patients with triple vessel disease, quality of life and symptom relief become more important than strict survival outcomes when selecting between revascularization strategies 7, 8
• CABG or PCI to improve symptoms is beneficial in patients with significant stenosis (>70% diameter) and unacceptable angina despite guideline-directed medical therapy 1, 2, 3

Key Clinical Pitfalls

• Avoid PCI in diabetic patients with triple vessel disease unless they are absolutely not candidates for CABG, as CABG provides superior survival benefit in this population 7, 8
• Never proceed with PCI for triple vessel disease without documented ischemia on objective testing, as this increases procedural risk without proven benefit 5, 6